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Background: Control of intracellular events by protein
phosphorylation is promoted by specific protein kinases.
All the known protein kinases possess a common struc-
ture that defines a catalytically competent entity termed
the 'kinase catalytic core'. Within this common structural
framework each kinase displays its own unique substrate
specificity, and a regulatory mechanism that may be mod-
ulated by association with other proteins. Structural stud-
ies of phosphorylase kinase (Phk), the major substrate of
which is glycogen phosphorylase, may be expected to
shed light on its regulation.
Results: We report two crystal structures of the catalytic
core (residues 1-298; Phkytrnc) of the y-subunit of rabbit
muscle phosphorylase kinase: the binary complex with
Mn2+/>3-y-imidoadenosine 5'-triphosphate (AMPPNP)
to a resolution of 2.6 A and the binary complex with
Mg 2+/ADP to a resolution of 3.0 A. The structures were
solved by molecular replacement using the cAMP-depen-
dent protein kinase (cAPK) as a model.
Conclusions: The overall structure of Phkytrnc is similar
to that of the catalytic core of other protein kinases. It
consists of two domains joined on one edge by a 'hinge',
with the catalytic site located in the cleft between the
domains. Phkytrnc is constitutively active, aid lacks the
need for an activatory phosphorylation event that is essen-
tial for many kinases. The structure exhibits an essentially
'closed' conformation of the domains which is similar to
that of cAPK complexed with substrates. The phosphory-
lated residue that is located at the domain interface in
many protein kinases and that is believed to stabilize an
active conformation is substituted by a glutamate in
Phkytrnc. The glutamate, in a similar manner to the
phosphorylated residue in other protein kinases, interacts
with an arginine adjacent to the catalytic aspartate but
does not participate in interdomain contacts. The interac-
tions between the enzyme and the nucleotide product of
its activity, Mg2+/ADP, explain the inhibitory properties
of the nucleotides that are observed in kinetic studies.
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Introduction
Protein modification by phosphorylation and dephos-
phorylation, catalyzed by members of the protein kinase
and protein phosphatase families, respectively, is a ubiqui-
tous regulatory mechanism in eukaryotic cells. It is a
readily reversible dynamic, switching mechanism that
alters the biological function of a protein by modulating
its structure and/or activity [1]. Glycogen phosphorylase
kinase (Phk) was discovered in 1955 and was the first
protein kinase to be recognized and characterized [2,3].
For approximately 10 years after this observation, func-
tional control by reversible phosphorylation was thought
to be a peculiarity of glycogen metabolism. Following
the discovery in 1968 of cAMP-dependent protein
kinase (cAPK) [4], an enzyme with broader specificity
and the capability of phosphorylating a number of
diverse proteins, the importance of phosphorylation in
other regulatory mechanisms was recognized.
Phk is one of the largest and most complex of the known
protein kinases, and is central to the regulation of glyco-
gen metabolism. This multimeric protein transduces and
integrates signals that affect glycogen metabolism; signals
take the form of multiple phosphorylation events and
altered intracellular concentrations of Ca2 +. Signals that
regulate Phk activity originate from the interaction of
extracellular compounds with their tissue-specific cognate
receptors. These compounds include the catecholamines
adrenaline and nor-adrenaline, and the peptide hormones
insulin, glucagon, angiotensin and vasopressin. Additional
control of Phk activity comes from signals involved in the
energy balance of the cell and from neuronal signals that
stimulate the release of Ca2+ from intracellular stores
[5,6]. It is this Ca2 + signal that also stimulates muscle
contraction. Consequently, the signal that initiates the
energy-requiring process of muscle contraction also stim-
ulates the breakdown of glycogen, the cell's major energy
store. By transducing and integrating these signals, Phk is
able to coordinate the energy requirements and energy
availability not only of individual cells but also of the
entire organism.
The major physiological substrate of Phk is glycogen
phosphorylase, although other substrates, such as glyco-
gen synthase, troponin I and the 3-subunit of Phk
itself, have been identified in in vitro studies. Phk cat-
alyzes the activation of glycogen phosphorylase through
phosphorylation of a single residue, Serl4.
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The Phk holoenzyme is hexadecameric, displaying the
subunit stoichiometry (at3y) 4 with a total molecular
weight of approximately 1.3 x 103 kDa. The a-, 3- and
B-subunits are regulatory whereas the y-subunit is cat-
alytic. The a- and 3-subunits (Mr 145000 and 128000,
respectively) transmit regulatory information via their
phosphorylation state. Protein kinases known to phospho-
rylate the a- and 3-subunits include cAPK, AMP-depen-
dent protein kinase (APK), and Phk itself [7,8]. The Ca2+
sensitivity of the holoenzyme is conferred by the 8-subunit
(Mr17000), which is essentially identical in sequence to
calmodulin [9]. The y-subunit (Mr45000; Fig. 1) contains
a kinase catalytic domain [10], a motif delineated by the
analysis of primary sequences of many protein kinases, and
a calmodulin-binding domain [11]. The calmodulin-bind-
ing domain may act to regulate activity through a pseudo-
substrate mechanism similar to that of myosin light chain
kinase (MLCK) whereby the Ca2+-bound form of
calmodulin can compete for the binding of a pseudosub-
strate sequence contained elsewhere in the protein [12,13].
The Phk catalytic domain, residues 1-298 of the Phk
-y-subunit, has been expressed in Escherichia coli and puri-
fied [14-16]. It displays activity comparable to that of the
activated holoenzyme and, as expected, exhibits no regula-
tion by Ca2 + or phosphorylation signals.
Structural analyses of cAPK complexed with a variety of
inhibitors, substrates and substrate analogues have defined
the basic architecture of the kinase domain and the essen-
tial features of substrate recognition [17-20]. The results
of structural studies on three other serine/threonine
kinases - the human cyclin-dependent kinase (CDK2)
[21], mitogen-activated protein kinase (MAPK; also
known as ERK2) [22], and twitchin kinase [23] - and
on the first tyrosine kinase [24] have confirmed the struc-
ture of the kinase fold and have begun to offer insights
into their regulatory mechanisms. The kinase catalytic
core is bilobal in structure, with the two lobes joined by
a single segment of polypeptide chain that appears to
function as a 'pivot' about which the two lobes can rotate
with respect to one another. The substrates bind in the
Fig. 1. Schematic representation of the
Phk y-subunit. The catalytic domain is
coloured red and the calmodulin-bind-
ing regulatory domain is coloured blue.
cleft between the two lobes, with the nucleotide sub-
strate interacting mainly with the small N-terminal
3-sheet lobe, and peptide substrate mainly with the large
C-terminal at-helical lobe. A stretch of amino acids,
termed the activation loop, is situated at the domain
interface at the 'mouth' of the cleft between the two
domains, and comes into close proximity with the pep-
tide substrate. This loop has been implicated in the
off/on switching of many kinases by phosphorylation
and in the binding of regulatory subunits and peptide
substrate to the kinase domain.
Here we report the structure, at 2.6 A resolution, of the
kinase catalytic core of the Phk y-subunit (Phkytrnc;
residues 1-298) complexed with Mn2+/AMPPNP (a
non-hydrolyzable analogue of the nucleotide substrate
Mg2+/ATP) and the structure of Phkytrnc complexed
with the nucleotide product of the phosphorylation
reaction, Mg2+/ADP, at 3.0 A resolution.
Results
The structure of Phkytrnc
The crystal structure of Phkytrnc was solved initially at
3.0 A resolution, by molecular replacement, using the
structure of the catalytic core of cAPK (residues 43-280)
(protein databank [PDB] number 4CPK) as the search
object and data collected from crystals grown in the pres-
ence of Mg2+/ATP. The structure was built with refer-
ence to the O database [25] and had satisfactory
stereochemistry (Table 1). Subsequently, data were col-
lected to 2.6 A resolution at 100 K from a crystal grown
in the presence of Mn2+/AMPPNP. The model obtained
at 3.0 A resolution was refined against the higher resolu-
tion, low temperature data, and will be discussed in detail
here (see Table 1). Inspection of the two structures
revealed that the 3.0 A resolution structure was, in fact,
complexed with Mg2 +/ADP rather than Mg 2+/ATP.
The structure of the Mg2+/ADP complex will be
discussed only where it differs from that of the
Mn2 +/AMPPNP complex.
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Part of the final electron-density map is shown in
Figure 2. Three regions of the molecule (correspond-
ing to residues 1-13, 53-63 and 292-298) lacked satis-
factory electron density. Examination of the model
suggests that the 13 N-terminal residues and the six
C-terminal residues may be mobile, as the first and last
located residues project into solvent. Residues 53-63
include an insertion of five residues with respect to
cAPK and are part of an external loop which, in cAPK,
is located near the peptide-inhibitor binding site.
Absence of electron density for these residues in the
Phkytrnc structure, which lacks the peptide substrate,
may indicate some mobility at the substrate recognition
site when the peptide is not bound.
Figure 3 compares the protein sequences and the sec-
ondary-structure assignments of Phkytrnc and cAPK.
Their overall architectures are shown in Figure 4a,b, from
which it can be seen that their topologies are similar. In
the following discussion we give the corresponding
residues for cAPK in curly brackets after giving those for
Phkytrnc. In the Phk'ytrnc crystal structure, the smaller
N-terminal domain comprises residues 14-108 {38-125}
and the larger C-terminal domain comprises residues
109-288 {126-298}. The root mean square (rms) differ-
ence between the Cot positions of 245 common residues
of cAPK and Phkytrnc is 1.3 A, close to the value
expected for two proteins with 33% sequence identity
[26]. The structural differences between the two proteins
are not evenly distributed. The largest differences occur
in the regions composed of surface loops and helices B, G
and H (nomenclature as in Knighton et al. [17]). The
remaining secondary-structure elements have the greatest
structural similarity. All of the invariant residues noted
amongst other protein kinases [27] are also conserved in
structurally equivalent positions in Phkytrnc.
The Phk-ytrnc chain begins at residue 14 with one turn
of a helix and then enters the first strand, 31, where a
proline is accommodated at the third position. The 131
strand ends at residue 27 in Phkytrnc and is followed by
an irregular turn between 131 and 32 (discussed below in
connection with nucleotide binding). There is a type I
turn between 132 and 133, and residues from the three
strands 31, 32 and 133 form a hydrophobic surface
against which the nucleotide packs. After the 133 strand
there is a break in the electron density between residues
53-63, corresponding to the small B helix in cAPK. The
sequence here shows no similarity to cAPK and includes
three consecutive glycine residues. The three other pro-
tein serine/threonine kinases whose structures are known
(CDK2 [21], MAPK [22] and twitchin kinase [23]) have
a deletion in this region relative to cAPK. Evidently
this region is structurally variable and this variability may
be important for conferring different regulatory and
Fig. 2. Representative electron density
from the final 2Fo-Fc map. SIGMAA
[62] weighted 2mFo-DFc electron den-
sity using phases from the final model is
shown in the vicinity of the
Mn2'+/AMPPNP and the nucleotide
phosphate binding loop. Contour level
corresponds to 1a. Contours more than
2 A from any of the displayed atoms
have been removed for clarity. The fig-
ure was prepared using XOBJECTS
(MEM Noble, unpublished program).





Space group P212121 P212,21
Cell a=47.9A, b=69.1 A, a=48.5A, b=68.1 A,
c= 112.9A c= 113.4A
Maximum resolution 3.0A 2.55 A
Observations 21 198 40 661




Non-hydrogen atoms 2172 protein, 2172 protein,
27 ADP 31 AMPPNP
Refined 2xMg2+ 2xMn2 + , 91 water
Rconvt 0.172 0.196
Rfreet; 0.264 0.298
Reflections used in R-factor
calculations (I/cl >3.0):
Number, completeness 5232, 76.2% 9161, 83.0%
(6.0-3.0A) (6.0-2.6 A)
Highest resolution shell 3.12-3.0A 2.71 -2.60A
completeness 57% 62.4%
Rmsds from ideal geometry:
Bonds§ 0.013 A 0.017A
Angles§ 1.75° 1.90
Pooled X# 16.4 ° 17.7°
Residues in most
favourable regions of
Ramachandran plot 84.1% 84.9%
*Rmerge =jljZ h,j-i-hl/jLhlh,j where Ihj is the jth observation of reflection h.
tRConv=EhlFobshHIFcalchl/YhlFobsh, where Fobsh and Fcalch are the
observed and calculated values, respectively, for structure factor h. Rfree is
equivalent to Rconv for a randomly selected 5% subset of reflections not used
in structure refinement. §As calculated by X-PLOR 3.1 [601. #As calculated by
PROCHECK [65].
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Fig. 3. The sequence and secondary struc-
tural elements of Phkytrnc and cAPK.
Secondary-structure elements are labelled
following the convention adopted for cAPK.
The diagram is colour coded: green, p-strand;
red, cx-helix; violet, 310-helix. The region
shaded grey in Phk-ytrnc corresponds to that
part of the structure which could not be
traced due to poor electron density. Sec-
ondary-structure assignments were made
using DSSP [63], and correspond to the fol-
lowing regions: 131 19-27; 132 31-38; 33
44-51; cC 65-80; 4 91-94; 135 98-104; cD
111-118; cxE 123-142; 36 145-146; 310A
152-154; 37 155-157; 138 163-165; [39
172-173; 310B 187-189; 310 C 192-194; F
209-224; aG 234-243; 310D 252-254; cxH
258-267; cl 278-281; (x 285-288. The figure
was prepared using ALSCRIPT [64].
substrate specificity properties upon the different kinases.
The chain continues with the aoC helix, which is more
exposed in Phkytrnc than in cAPK. The otC helix in
cAPK contains four charged residues and is partly
shielded by the inhibitor peptide and the C-terminal
extension in the region of residues {346-350}. In
Phkytrnc the oLC helix contains eight charged residues,
of which seven are exposed (Glu65, Arg67, Glu68,
Lys72, Asp75, Arg78, Lys79) and one is buried (Glu73).
The buried Glu73 {Glu91} forms an ion pair with Lys48
{Lys72}, an important residue at the nucleotide recogni-
tion site. The N-terminal domain is completed with the
antiparallel 1-strands 4 and 35.
The chain between the domains in the region of residues
103-112 {120-129} is well localized and contains the
region defined as the 'domain hinge' in cAPK. The
amide groups from residues at the start of the otD helix
interact with the main-chain carbonyls from the P7
strand. The oaD helix has one external face where three
acidic residues are located, on adjacent turns of the helix
(GlullO, Aspll3 and Glu117). The chain then makes a
direct turn into the tE helix followed by the antiparallel
strands 6 and 7. The key catalytic aspartate, Asp149
{Aspl66}, is located in the loop between strands 36 and
17. There is then an irregular turn from 137 into P8
which contains the sequence Asp-Asp-Asp, all residues of
which are exposed. The 3-sheet structure is completed
by the antiparallel strands 8 and 39. At the end of 39
there is a two amino acid Pro-Gly insertion which is
accomplished by a type II turn with the obligatory
glycine residue (Gly177) in the third position. The fol-
lowing residues 178-185 {193-200} correspond to the
activation loop in cAPK, and the main-chain conforma-
tion of this region of the two kinases is similar. Glu182
occupies the position of {Thr197}, which is phosphory-
lated in cAPK and is discussed below.
The chain then enters the long (15 residue), buried aF
helix. As in cAPK, an ion pair which is inaccessible to
solvent is formed by Asp211 {Asp220} from the otF helix
and Hisl41 {Hisl58} from the otE helix. This region
also contains a hydrophobic pocket, residues Pro227-
Trp230, which is conserved in cAPK {Tyr235-Phe239}
and which is involved in the tight binding of an aromatic
residue from the naturally occurring peptide inhibitor
PKI (protein kinase inhibitor). The conservation of the
pocket between the -two molecules suggests that it may
also be involved in pseudosubstrate binding by Phk. The
residues adjacent to this pocket, His231, Arg232, Lys233
and Gln234, form a type III turn and possess high tem-
perature factors, indicating flexibility, which may be
important in, and consequently abrogated by, pseudosub-
strate binding. The otG helix (residues 235-243) is poorly
defined, and despite its hydrophobic nature (it possesses
the sequence Met-Leu-Met-Leu-Arg-Met-Ile-Met) it is
located on the exterior of the molecule. The corre-
sponding structure in cAPK is displaced by about 2.5 A.
The otG helix is followed by the insertion at residues
250-253, which directs the chain into a different path
from that of cAPK in the region of residues 248-257, but
several of the non-polar aromatic packing interactions are
conserved. For example the Phkytrnc cluster of Tyr246,
Phe248 and Trp253 replaces the cluster {Val255},
{Phe257}, {Pro258} and {Phe261} in cAPK. Both
CDK2 and MAPK have extensive insertions just before
the H helix and this part of the molecule is another
structurally variable region. The xoH helix (residues
258-267) is also displaced with respect to cAPK (by
approximately 2 A) but performs a structurally equivalent
role. The helix is followed by the conserved arginine
Arg275 {Arg280}, which makes an ionic interaction
between the conserved Glu193 {Glu208}.
The structural similarity between Phkytrnc and cAPK
extends beyond the conserved arginine, Arg275
{Arg280), into the I helix after a four residue deletion in
Phkytrnc (Fig. 2). The I helix packs against residues
134-138 of the E helix and following the I helix there are
a number of non-polar contacts that include Phe286 and
Phe287, which mimic the roles played by {Trp296} and
{Phe297} in cAPK. Huang et al. [15] have shown that the
y-subunit, when truncated at residue 276, exhibits only
4% of the activity of the y -subunit when it is truncated at
residue 300. This difference in activity can be ascribed to
the absence of the I helix, as residues 1-276 contain the
conserved arginine (Arg276), which participates in a
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Fig. 4. The structure of Phkytrnc and its
comparison with that of cAPK. Repre-
sentations of the tertiary structures of
(a) Phkytrnc and (b) cAPK, with
ct-helices and P-sheets depicted as
tapes and arrows respectively. The dia-
grams are colour ramped blue to red
from the N to C terminus. In cAPK the
additional residues at the N terminus
(including the A helix) are shown in
blue, the extended C-terminal tail in
red, and the inhibitor peptide is shown
in white. Mn2+/AMPPNP is shown in
Phkytrnc and Mg2+/ATP in cAPK as
ball and stick models. (c) Stereo dia-
gram of the CcY trace of Phkytrnc with
every 10th Ca position indicated with
a sphere, and labelled with the corre-
sponding residue number. The figure
was prepared using XOBJECTS (MEM
Noble, unpublished program).
stabilizing salt bridge, but not the I helix. The I helix is
far from the catalytic site and it is assumed, therefore, that
it plays a role in conformational stability. The last residue
of Phkytrnc that can be identified in the electron-density
map is residue Val291, at which point the chain appears to
be directed in a different direction from cAPK.
The nucleotide-binding site
Binary complex with the substrate analogue Mn2+/AMPPNP
In crystals which were grown in the presence of
Mn2+/AMPPNP, electron density for the metal atoms,
the base, ribose and all three phosphate groups was
apparent. The two manganese ions had the highest elec-
tron density values in the refined 2Fo-F c electron-density
map. The interactions of the nucleotide complex
Mn2 +/AMPPNP with Phkytrnc are shown in Figure 5.
Overall, the conformation of the nucleotides bound to
cAPK and Phkytrnc is similar. The ribose has a C3'-endo
conformation with the conformation about the glycosyl
bond anti (X=- 16 6 ) and the orientation about the
C4'-C5'+sc (y=48°) following the nomenclature of
Saenger [28].
The purine-binding site
The purine base is almost completely buried in a
hydrophobic pocket at the interdomain cleft and is
bound to the enzyme by hydrogen bonds between the
N6 and the carbonyl oxygen of Aspl04 {Glu121 } and
between N1 and the main-chain amide of MetlO6
{Va1123}. In cAPK, a direct hydrogen bond exists
between N7 and {Thrl83}. In Phkytrnc, the equivalent
interaction is replaced by a hydrogen bond to a water
molecule that also contacts N6. The equivalent threo-
nine, Thr166, is 4.1 A from N7. Extensive van der Waals
interactions are made between the purine and Leu25
{Leu49}, Val33 {Val57}, Ala46 {Ala70} (from strands
1, 32 and 3, respectively, of the N-terminal 13-sheet
domain), Ile87 {Vall04}, PhelO03 {Metl20} from 35,
MetlO06 {Va1123} at the domain boundary and Leul56
{Leul73} from the C-terminal domain. In the cAPK
structure the purine has additional shielding from
{Phe327} in the C-terminal portion of the chain not
present in Phkytrnc. Val33, a residue that follows the
'glycine' phosphate recognition loop, appears to play an
especially important role in the binding of the nucleo-
tide as the Phk y-subunit mutant, Val33---Ala, exhibits
negligible nucleotide binding [29].
The ribose-binding site
The ribose, in the C3'-endo conformation, is bound to
the Phkytrnc enzyme through hydrogen bonds from
the 02'-hydroxyl to the carboxyl group of Glul 10
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Fig. 5. The Mn2+/AMPPNP binding site
in Phkytrnc. (a) Stereo diagram of the
spatial disposition of residues contact-
ing Mn2+/AMPPNP as displayed by
XOBJECTS. Labels are given for any
residue with any atom within 3.5 A of
the bound nucleotide, and dotted lines
indicate polar-polar contacts of 3.2 A or
less. The side chains of Phel103 and
Arg27 have been deleted for clarity,
although the adenine base packs in
an edge to face fashion against the
phenyl ring of Phel03. (b) Schematic
diagram of polar contacts between
Mn2+/AMPPNP and Phkytrnc. Residues
making potential polar contacts shorter
than 3.3 A are included. The figure was
prepared using XOBJECTS (MEM Noble,
unpublished program).
{Glu127} and from 03'-hydroxyl to the main-chain
carbonyl oxygen of Glu153 {Glu170}. In cAPK there is
an additional hydrogen bond from 03' to the side chain
of an arginine residue from the recognition site of PKI.
The phosphate/metal ion binding site and the glycine
phosphate recognition loop
As demonstrated in other protein kinases, many of the
interactions made by the phosphate groups of the
nucleotide are mediated by the bound metal ions. There
are hydrogen bonds from both the o- and 3-phosphate
oxygens to NC Lys48 {Lys72}. Lys48 in turn is hydrogen
bonded to Glu73 {Glu91}, as in cAPK, and appears to
provide a major stabilizing interaction for the triphosphate
moiety. The remaining interactions are through the metal
ions. One manganese ion (Mn2) bridges the 3- and
y-phosphate oxygens and is also linked to Asp167 O81.
The other manganese ion, Mnl, bridges the or- and
y-phosphate oxygens and is linked to Asn154 O81 and
Asp167 082. The assignment of water molecules in the
structure has been conservative and no firmly located
waters have been detected in the vicinity of the metal ions.
The contacts from phosphates to the glycine phosphate
recognition loop are different from those observed in the
ternary complexes with cAPK. The conformations of
residues 26-32 (Gly-Arg-Gly-Val-Ser-Ser-Val) are similar
to the equivalent residues 50-56 in cAPK (Gly-Thr-Gly-
Ser-Phe-Gly-Arg) but the loop is displaced away from the
phosphate binding sites as indicated in Figure 6. The
Cot atoms of residues Arg27, Gly28, Val29 and Ser30 are
displaced between 1.2 A and 2.7 A with respect to the
positions of equivalent residues in cAPK so that the
main-chain amide groups in Phkytrnc are not involved in
hydrogen bonds to the phosphates. It is possible that the
side chain of Ser31, which replaces the third glycine in
cAPK, causes some displacement of the loop (Ser31 Oy
is 3.7 A from -phosphate oxygen) or that binding of
substrate in the ternary complex results in a shift of the
glycine phosphate recognition loop to tighten the site, as
observed in cAPK complexes [19]. Mutation of Ser31 to
a glycine (the homologous residue in cAPK) had no sig-
nificant effect on the phosphotransferase activity, although
it did affect some of the parameters along the reaction
pathway, resulting in decreased ATP affinity and increased
ADP affinity [29]. The side chain of residue {Ser53}
forms a hydrogen bond with the carbonyl oxygen of the
phosphorylated residue in the substrate. However, in
Phkytrnc this residue is a valine, Val29, and consequently
such an interaction would not be possible. Mutation of
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Fig. 6. Comparison of the nucleotide
phosphate binding loops in Phk'ytrnc(white) and cAPK (grey). The nucleotide
phosphate binding loops of Phkytrnc
and cAPK are shown together with the
nucleotide, the crucial lysine (Lys48),
and the catalytic base (Asp149). The
loop of Phkytrnc is somewhat more
open, and the active site of Phkytrnc
appears to be more accessible, due to
the presence of Ser31 in Phkytrnc in
place of Phe54} in cAPK. The figure
was prepared using XOBJECTS (MEM
Noble, unpublished program).
Val29 to serine produced an enzyme with diminished
activity, although both binary complexes of this mutant
had increased affinity for the second substrate. Evidently,
the glycine phosphate recognition loop in Phkytrnc pro-
vides a sensitive discriminator for catalysis and substrate
affinity. Further structural interpretation of the individual
components must await the determination of the ternary
complex structures with ATP and substrates.
{Lys168} is involved in the binding of the y-phosphate
of ATP or ATP analogues. The equivalent residue in
Phkytrnc is Lys51, which makes an ionic interaction
with Glu153 {Glu170}, whose main-chain carbonyl
oxygen is involved in a hydrogen bond to the ribose. The
amino group of Lysl51 is 3.8 A from the y-phosphate
group of AMPPNP. Its location at the nucleotide-bind-
ing site and its probably similar role in binding ATP to
that observed for {Lysl68} in cAPK are consistent with
chemical modification studies which have shown that this
residue is labelled by adenosine triphosphopyridoxal [30].
Binary complex with nucleotide product Mg2+/ADP
The electron density at 3.0 A resolution, calculated from
data collected from crystals grown in the presence of
Mg2+/ATP, showed no indication of the terminal
y-phosphate of the nucleotide. It is known that Phk
holoenzyme and the y-subunit on its own show signifi-
cant Mg2 +-dependent ATPase activity corresponding to
approximately 0.2% of the phosphorylase conversion
activity [31]. Moreover, ADP binds tightly to both the
y-subunit and Phkytrnc and acts as a competitive
inhibitor with an inhibition constant (Ki) of approxi-
mately 50 pLM [14,32] and a Kd for the holoenzyme of
2-3 p.M [31]. Hence it is likely that hydrolysis of ATP
to ADP has occurred during crystallization and that
the product, Mg 2+/ADP, has remained bound to the
kinase. The Mg2 + ions in the Mg2 +/ADP complex have
been assigned on the basis of significant electron-density
peaks in positions structurally equivalent to the Mn2 +
ions of the Mn2+/AMPPNP complex. The positions of
the purine, ribose and metal ions in the complex
were almost identical to those in the Mn2 +/AMPPNP
complex. There is, however, a difference between the
positions of the o- and 3-phosphates in the two com-
plexes. In the ADP complex, one magnesium ion, Mgl,
links the ox- and P-phosphate oxygens and interacts with
Asn154 and Aspl67. The other Mg2+ ion, Mg2, is
bound to the 13-phosphate and to Asp167. The change
in liganding of M1 from the ox- and y-phosphates in the
Mn2+/AMPPNP complex to the x- and 3-phosphates
in the ADP complex most probably occurs in order that
the increased negative charge on the 3-phosphate can
be stabilized.
In the Mg2+/ADP complex there is also a concerted
movement of the glycine phosphate recognition loop
towards the phosphates, so that in the Mg2/ADP com-
plex, the loop occupies a position in between that
observed for the Phkytrnc Mn2+/AMPPNP complex
and cAPK. As a result, in the ADP complex, Ser31 NH
is 3.5 A from the 3-phosphate oxygen (compared with
4.1 A in the Mn2+/AMPPNP complex), and Ser30 O'y
is 3.4 A from the 3-phosphate (compared with 5.7 A in
the Mn2+/AMPPNP complex). The net result of these
changes is to increase the enzyme/ADP interactions
compared with the enzyme/AMPPNP interactions. The
structures may explain the observation that dissociation
rates for the ADP complex are generally lower than those
for the ATP complex [29]. In cAPK the phosphorylation
rate constant is so high that the rate determining step is
product release [33].
Metal-binding sites
Phk activity is increased by free Mg2 + and inhibited by
free Mn2+ as observed for the holoenzyme, the catalytic
subunit and the truncated catalytic subunit Phkytrnc
[14,32]. Activity increases as Mg2+ concentrations are
raised until they are equimolar with ATP; a further
three-fold increase occurs as Mg2 + levels are raised to
about 10 times those of ATP. With Mn2 + there is an
equivalent activation as concentrations are raised until
they are equimolar with ATP, followed by inhibitory
effects as Mn2 + concentrations are further increased. This
behaviour is slightly different from that observed with
cAPK, where the binding of one Mg 2+ ion is essential
for activity but binding of a second Mg 2 + ion is
4sp 149 p149
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inhibitory [34]. Mn 2+ binding to the high affinity site in
cAPK leads to a four-fold lower activity than with Mg2 +
and binding of Mn2 + to the second site is inhibitory. In
cAPK, crystallographic [19,35,36] and kinetic experi-
ments [34] have assigned the high-affinity activating
Mg2+ site to that occupied by the Mg2+ that bridges the
B- and y-phosphates of ATP and binds to {Asp184} (M2
metal site). The low-affinity inhibitory Mg2+ site has
been assigned to that occupied by the Mg2+ that bridges
the o- and y-phosphates of ATP and binds to {Asnl71 }
(M1 metal site).
By analogy, the Mn2 site in Phkytrnc corresponds to the
activating site in cAPK and the Mnl site corresponds to
the inhibitory site. Possible roles for the metal ions in
nucleotide binding and catalysis were discussed by
Knowles [37] and include the following possibilities. In
the nucleotide triphosphate complex, the metal ion (M2)
that bridges the 3- and y-phosphates of ATP may act to
stabilize the developing negative charge on the oxygens
of the transferring phosphate group. This would require a
change in the metal position or its coordination during
catalysis which has been observed in different complexes
with phosphofructokinase [38] and which is observed in
Phk-ytrnc where coordination of the metal/phosphate
changes between Mn2 +/AMPPNP and Mg2+/ADP
complexes. The metal M1 coordinates the (x- and
y-phosphates for AMPPNP and the oa- and 3-phosphates
in ADP Whether the metal at Ml acts as an activating
site or an inhibitory site may reflect the balance between
the extent to which the metal can favour product forma-
tion or inhibit product release. An alternative is that the
metal ions are firmly positioned and act as a template for
the precise positioning of the oligophosphate chain with
respect to the protein substrate and catalytic groups. The
tight-binding site observed in the protein kinases would
be consistent with this role. Yet another possibility is that
the metal ion coordinates with two oxygens from the
transferred phosphate group and acts to favour
ground-state distortion towards the trigonal-bipyramidal
transition state as proposed for phosphofructokinase [38].
However, this role is not consistent with the structure of
Phkytrnc complexed with Mn2 +/AMPPNP, in which
neither the Mnl site nor the Mn2 site is coordinated by
more than one oxygen of the y-phosphate.
Nucleotide binding site phosphorylation
Malencik et al. [39] have reported that a 30 kDa, catalyti-
cally active fragment of Phk undergoes an autophospho-
rylation on Ser30. In the crystal structures there is no
additional density in the final electron-density map at the
position of Ser3O to indicate that autophosphorylation
has taken place, although the sequence around Ser30
shows partial features of a Phk-specific recognition
sequence [5]. The side chain of Ser30 is directed towards
the -phosphate (the closest separation to the phosphate
oxygen is 3.6 A in the Mg2+/ADP complex, which falls
just outside the limit for hydrogen bonds). Phosphoryla-
tion on Ser30 would probably inhibit the binding of
nucleotide. The presence of a serine residue, Ser30, at
the apex of the loop in place of a bulky aromatic residue
that is seen in most kinases (such as {Phe54} in cAPK)
results in the nucleotide phosphate binding site being
more 'open' in Phkytrnc (Fig. 6). This effect may be
further accentuated by the raised conformation of the
glycine phosphate recognition loop in Phk-ytrnc. The
phosphate groups of the nucleotide may be more accessi-
ble to attack by water molecules than is the case with
cAPK and this may, in part, provide an explanation for
the ATPase activity displayed by Phkytrnc [31].
Domain orientation
Open and closed conformations have been identified for
cAPK both from solution scattering studies and from
X-ray crystallography [19,35,36,40-42]. The transition
between the open and closed conformations has been
characterized as a concerted rotation of the small N-ter-
minal domain relative to the larger C-terminal domain,
of approximately 150 (in the crystal studies) and 30° (in
the solution studies). Open structures have been observed
in the crystal studies of inactive forms of MAP kinase and
twitchin kinase, whereas with the inactive form of
CDK2 the domain interface region does not correspond
to either of the canonical structures. The hinge region in
cAPK includes residues {Gly125} and {Gly126}.
Glycine residues are frequently found in these positions
throughout the kinase family, and their conservation
probably indicates functional importance [42]. However,
an exception is the Phk y-subunit, where the sequence
in this region is Lys-Gly.
Coordinates for the C-terminal domain (residues
110-292) of Phkytrnc were superimposed on the coord-
inates for the corresponding C-terminal domain of
cAPK ternary complex. For both the Mn 2 +/AMPPNP
and the Mg2 +/ADP complexes, superimposition of the
N-terminal domains required a rotation of 5 of the
N-terminal domain, with respect to the C-terminal
domain, as shown in Figure 7. The relative domain ori-
entation in the structure of Phkytrnc complexed with
Mn2 +/AMPPNP appears essentially closed and is similar,
but not identical, to that of the closed conformation of
the ternary cAPK complex.
Four factors appear to promote the closed conformation
of the binary Phkytrnc complex. Firstly, the nucleotide
makes contacts with both the N-terminal and C-termi-
nal domains and with the hinge region, and these con-
tacts will be promoted with the domains in a closed
conformation. In particular, Glul10, which directly
follows the hinge region, makes a hydrogen bond to the
03'-hydroxyl of the ribose and Glu153 interacts with
the 02' of the ribose (a similar interaction is observed in
the ternary complex of cAPK). Secondly, the hinge
region in Phkytrnc has the sequence LyslO8-GlylO9, in
place of the {Gly-Gly} sequence observed in cAPK and
also in many other kinases. This may result in the hinge
being rather more rigid in Phkytrnc. A third factor
favouring domain closure is a lattice contact made by the
packing of Tyr290' from a neighbouring molecule in a
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Fig. 7. Comparison of the Ca traces of Phkytrnc (white) and
cAPK (grey). The view is along the axis about which relative
domain motion is maximum. The Phk-ytrnc structure is in a more
'open' conformation by approximately 5.00. The figure was pre-
pared using XOBJECTS (MEM Noble, unpublished program).
hydrophobic pocket formed from residues that include
Lysl08 and Gly109 (Fig. 8). We note that in cAPK the
C-terminal region (residues {323-328} and {314-318})
comes close to the hinge region and could confer some
rigidity in that kinase. Finally, glycerol, which was added
to the crystallization medium and resulted in improved
order of the crystals, may also promote a closed confor-
mation by decreasing the water content while still pro-
viding a polar solvent which can hydrate the protein
surface but not the polar clefts [43]. All four factors
appear to play a role in shifting the equilibrium to favour
a closed conformation. In the Phkytrnc structure a sig-
nificant influence favouring a closed conformation
appears to be the binding of nucleotide and the specific
and numerous hydrogen bonds and van der Waals inter-
actions it makes with both domains. By contrast, in
crystal soaking experiments, ATP was observed to bind
to the open forms of CDK2 and MAPK [21,22]. It is
possible that domain closure was not triggered in these
binary complexes either because the kinases were in
their inactive forms or because closure was hindered by
the crystal lattice.
The activation loop
The region in protein kinases corresponding to residues
{192-200} in cAPK has been termed the activation loop
[44]. This loop links strand 139 and a segment of the
peptide chain that is involved in the peptide substrate
recognition site. It has been implicated in defining the
Fig. 8. The hinge region of Phkytrnc. The Ca trace of Phkytrnc is
shown in a view similar to that of Figure 7, together with the
bound nucleotide and residues of the hinge region (carbon atoms
coloured green). The relative disposition of N- and C-terminal
domains may be influenced by the interaction of Glu 10 with
the 03' of the nucleotide. Residues from the C terminus of a
neighbouring molecule (carbon atoms coloured cyan) may affect
the stability of this hinge conformation in the crystal structure.
The figure was prepared using XOBJECTS (MEM Noble,
unpublished program).
catalytic activity of the protein kinases [17] and the
association of regulatory subunits [45,46]. In cAPK it
includes residue {Thrl97} which is phosphorylated by
an autophosphorylation mechanism immediately after
synthesis to give an active recombinant enzyme which
is resistant to dephosphorylation. The phosphorylated
threonine is involved in a network of hydrogen bonds
and electrostatic interactions. Mutation of {Thrl97}
to alanine results in substantial loss of activity [47], im-
paired stability, and altered regulatory subunit binding
[45]. In more recent kinetic studies [48], mutants
{Thrl97-Asp} and {Thrl97--Ala} were shown to
exhibit reduced catalytic efficiency due to specific effects
of weakened ATP affinity and reduced rates of phospho-
ryl transfer, with no effect on the binding of peptide sub-
strates. Most protein kinases are known to be regulated
by phosphorylation/dephosphorylation of equivalent
residues in this region: for instance, the cell cycle kinase
CDK2 is activated by a combination of phosphorylation
of the equivalent residue, Thr160, and binding of cyclin.
In the yeast homologue, p34cdc2 kinase, there is evidence
that the replacement of threonine by glutamate leads to a
partly active non-regulated enzyme and results in incor-
rect mitosis, [49]. In MAPK, phosphorylation on both
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Thrl83 and Tyr185 in this region is necessary for activa-
tion of the kinase. The crystal structures of CDK2 and
MAPK in their inactive non-phosphorylated forms show
that the activation loop in each of these enzymes has a
conformation that is very different from the conforma-
tion in cAPK. The insulin receptor tyrosine kinase
domain exhibits a novel auto-inhibitory mechanism
whereby one of the activation loop tyrosine -residues,
which is autophosphorylated in response to insulin, is
bound at the active site [24]. Twitchin kinase is not reg-
ulated by phosphorylation but by calcium/calmodulin
interactions. In this kinase the activation loop has a dif-
ferent conformation to that in cAPK and is in an open
inactive conformation in which it is inhibited by its own
C-terminal calmodulin-binding domain via an intrasteric
mechanism.
Phkytrnc is constitutively active and does not require
post-translational modification. In Phkytrnc, the residue
corresponding to {Thrl97-P} is Glu182. The conforma-
tions of the activation loops around {Thr197-P} in
cAPK and Glu182 in Phkytrnc are very similar. After the
Pro-Gly insert in the type II turn in Phkytrnc, the
main-chain atoms superimpose closely (Fig. 9). In cAPK,
{Thrl97-P} contacts {His87}, from the N-terminal
domain, and {Lysl89} and {Argl65}, from the C-termi-
nal domain (Fig. 10a). {Argl65} is adjacent in sequence
to the catalytic base {Asp166}. In Phkytrnc, the side
chain of Glu182 has high temperature factors (50 A2 for
side-chain atoms as compared with the average B-factor
for all atoms of 36 A2) and adopts one of the less
favoured conformations. In this position, the closest
approach of a carboxylate oxygen to Argl48 {Argl65} is
2.9 A (Fig. 10b). Arg148 also forms a hydrogen bond
(3.1 A) to Tyr206 (an interaction that is made in cAPK)
and is partially exposed to solvent. The residue in
Phkytrnc that corresponds to {His87} is Ala69, which is
well localized but displaced from the site. Its displace-
ment helps to create a more open structure around the
Arg148 residue. The side chain of Glu182 also interacts
with a chain of water molecules which takes up a posi-
tion similar to that of His87 in cAPK. In Phkytrnc the
residue corresponding to {Lys189} is Cysl72. It is inter-
esting to note that Cys172 is in close proximity to
Argl48 (3.7 A) and Lys72 (2.7 A). In this basic environ-
ment the thiol group of the residue may, in fact, be a
thiolate ion.
Thus, in Phkytrnc and cAPK, the activation loops adopt
similar conformations. Both loops include a stabilizing
ionic interaction with the conserved arginine adjacent to
the catalytic aspartate, Asp149 {Asp166}, mediated by
Glu182 in Phkytrnc and by {Thrl97-P} in cAPK, that
may act as a means of communication between the acti-
vation loop and the catalytic machinery. The loop does
not, however, appear to play a role in interdomain inter-
actions in Phkytrnc. Overall the structure around the
conserved arginine is more open than in cAPK. In the
holoenzyme, however, there are two large regulatory
subunits (o- and -subunits) associated with each
Fig. 9. The activation loop. The activation loops of Phkytrnc (car-
bon atoms coloured yellow), and cAPK (carbon atoms coloured
magenta) are displayed, after superimposing the two structures
on the basis of the whole molecules. The position of the carboxy-
late of Glu182 corresponds to the position of the phosphate of
the phosphorylated residue (Thr1971. The figure was prepared
using XOBJECTS (MEM Noble, unpublished program).
'y-subunit and the whole structure is hexadecameric. In
this environment, the activation loop may not be
exposed to solvent, and the interactions made by Glu182
may therefore be relatively stronger. It is also possible that
in the holoenzyme additional interactions will be formed
with the residues in the activation loop and that the role
of water molecules may be taken over by residues in the
regulatory subunits.
Substrate recognition
The subsites that accommodate the amino acids of pep-
tide substrates or inhibitors are labelled according to the
nomenclature of Knighton et al. [18], in which the Ser-P
phosphorylation site is labelled P and sites N-terminal
and C-terminal to this as P-1 and P+1, and so on.
Glycogen Phk recognizes the consensus sequence
Lys/Arg-X-X-Ser*-Val/Ile, where X denotes an unspec-
ified amino acid, as deduced from its ability to phospho-
rylate glycogen phosphorylase, glycogen synthase and the
3-subunit of Phk [50]. Phk exhibits activity against syn-
thetic peptides from residues surrounding Serl4 in the
phosphorylase sequence, although Vnmax against peptide
substrates is only half that determined with phosphory-
lase and the Km for a tetradecapeptide is 75-fold higher
than the Km for phosphorylase [51]. These observations
suggest that other regions of the phosphorylase molecule,
as well as the local sequence surrounding the phosphory-
lation site, also play a role in the recognition by the
kinase. Peptide substrates have been used to obtain addi-
tional information on the relative contributions of indi-
vidual amino acids and substitution of any of the residues
in the sequence Lys-Gln-Ile-Ser*-Val-Arg has a signifi-
cant effect on catalysis [52]. In particular, Phk has a pref-
erence for an arginine in the P+2 position. The presence
of this arginine in phosphorylase accounts for the
enhanced activity of Phk on phosphorylase compared
with glycogen synthase and also explains why phos-
phorylase is not a substrate for cAPK [5].
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Fig. 10. Contacts made by the activation loops of cAPK and
Phkytrnc. (a) Contacts of the phosphorylated threonine residue,
IThr197} in cAPK, include contacts to residues of the N-terminal
domain, and to Argl 651, which is adjacent to the catalytic base.
(b) Details of the contacts made by Glu182 in Phkytrnc. The
O81 of Glu182 interacts with Arg148 (equivalent to Arg165) at a
distance of 2.9 A. Arg148 also makes an interaction with Tyr206,
although no close contacts are made with residues of the N-ter-
minal domain. Residues Ala69 and Cys172 are equivalent to(His871 and (Lys1891 in cAPK and are shown for comparison.
The figure was prepared using XOBJECTS (MEM Noble, unpub-
lished program).
Although we have not yet determined the structure of
Phk-ytrnc complexed with peptide substrates, some infor-
mation on the likely specificity determinants can be
deduced by comparison of the Phkytrnc structure with
the peptide inhibitor-bound structure of cAPK. Both
enzymes show specificity for a basic residue at the P-3
position. In cAPK an arginine from PKI interacts with
{Glu127}, {Glu331} and the main-chain carbonyl
oxygen of {Thr51}. In Phkytrnc, residues Glul10
{Glu127} and Arg27 {Thr51} (main chain) are in struc-
turally equivalent positions and could stabilize a basic
group at this site, but there is no acidic group corre-
sponding to {Glu331 }. At the P-2 position in cAPK the
second arginine contacts {Glu170} and {Glu230}. In
Phk-ytrnc Glu153 is structurally equivalent to {Glu170}
but the residue corresponding to {Glu230} is Thr221.
This change could provide a suitable environment for the
glutamine residue in the P-2 position of Phkytrnc sub-
strates. The P-1 position in the inhibitor complex of
cAPK is occupied by an asparagine which hydrogen
bonds to {Ser53}. In Phkytrnc there is a preference for a
non-polar residue at this site and the change of {Ser53}
to the structurally equivalent Val29 would provide a satis-
factory environment. The positions of the key catalytic
aspartates, Asp149 and {Aspl66}, are very similar in the
two structures and it is assumed that Phkytrnc operates
through a similar catalytic mechanism to cAPK. The P+ 1
site is occupied by non-polar side chains in both
enzymes. In cAPK the isoleucine at the P+1 site of PKI
sits in a hydrophobic pocket created by {Leul98},
{Gly200}, {Pro202} and {Leu205}. The equivalent
residues in Phkytrnc (Val1183, Gly185, Leul90 and
Pro197) can provide the same non-polar determinant for
this site. The largest change in specificity is at the P+2
site. In the cAPK inhibitor complex this site is occupied
by histidine, which packs against {Phe54} and {Leu82}.
A larger basic side chain such as an arginine residue could
not be accommodated at this site. In Phkytrnc the posi-
tion of {Phe54} is taken up by the smaller amino acid,
Ser30O. The residue corresponding to {Leu82} is in the
loop containing residues 55-63, which has not been
located. We note that this region contains a number of
glutamate residues that may stabilize the arginine in
Phk'ytrnc substrates. It can be inferred from multiple
sequence analysis that similar interactions may occur in
protein kinase C, which also possesses a number of acidic
residues in this region and also recognizes a basic P+2
residue [53]. The present structure provides a satisfactory
account of the substrate specificity of Phkytrnc but
this will have to be confirmed by X-ray structures of
enzyme-substrate complexes.
The N-terminal region of glycogen phosphorylase is
basic and this property was noted by Fischer et al. [3],
who speculated that it might play a role in the activation
mechanism. Analysis of the structural changes that
accompany the activation of glycogen phosphorylase on
phosphorylation has shown that electrostatic effects are
indeed important [54]. In the non-phosphorylated form,
the basic N-terminal tail is located at an acidic region on
the phosphorylase surface. Display of the surface electro-
static potential of the Phkytrnc molecule with GRASP
[55] shows that the catalytic site of the kinase displays a
similar negative electrostatic potential (Fig. 11), which no
doubt contributes to the enzyme's specificity for basic
residues that surround the site of phosphorylation.
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complex. It is apparent that very little conformational
change occurs after catalysis to destabilize binding of the
nucleotide reaction product, Mg2 +/ADP, as compared
with the substrate Mg2+/ATP. In the Mg2+/ADP
complex the oa- and 3-phosphate positions shift slightly
in order to make contact with the metal ions and thus
stabilize the complex formed as a result of the loss of the
y-phosphate from ATP. These shifts, together with those
of the glycine loop, could explain the inhibitory
properties of ADP.
Fig. 11. The surface of Phkytrnc, coloured according to electrosta-
tic potential. The molecular surface and electrostatic potential
were calculated and displayed using the program GRASP [55].
The inhibitor peptide from the cAPK structure (PKI) is shown in
the position it occupies when the ternary complex of cAPK is
superimposed on the Mn2+/AMPPNP complex of Phkytrnc. The
protein surface close to the probable site of interaction with sub-
strate peptide is predominantly negative.
Discussion
The structure of Phkytrnc represents the fifth serine/
threonine protein kinase structure to be solved and the
first of a constitutively active kinase. The results show
that the fold in this kinase is similar to that in the active
form of cAPK in its ternary complex with both ATP and
inhibitor peptide, but different from the structures of the
inactive forms of CDK2, MAPK and twitchin kinase.
The activation loop of Phkytrnc, which in cAPK, CDK2
and MAPK is subject to phosphorylation, adopts the
apparent active conformation without the need for ionic
interactions promoted by a phosphorylated group.
Glu182 occupies a similar position to that of {Thrl97-P}
in cAPK and may assume a similar role in providing a
means of information transfer to the catalytic site but
does not directly promote interdomain interactions. Both
binary complexes of Phkytrnc (with Mg2 +/ADP or
Mn2 +/AMPPNP) exhibit closed structures in terms of
the relative dispositions of the N- and the C-terminal
domains. This is promoted primarily by contacts from
both N- and C-terminal domains to the nucleotide, and
also by a less flexible amino acid composition in the
hinge region. Notably, one residue that coordinates the
ribose of the bound nucleotide, GlullO, comes directly
from the hinge region, and so may play a role in a
switching mechanism. The structure appears to be poised
for catalysis without the need for substantial con-
formational changes, but there may be minor shifts, such
as the tightening of the glycine phosphate recognition
loop around the nucleotide phosphates in the ternary
In 1958, Koshland [56] introduced the notion of induced
fit to explain the specificity of enzymes. He noted, for
example, that hexokinase exhibited no ATPase activity
and only transferred the y-phosphate of ATP to the
6-OH group of glucose. It was proposed that binding of
both substrates brought the catalytic groups into their
correct conformations for catalysis and that neither
substrate alone could promote these changes. Phkytrnc is
constitutively active and requires no post-translational
modifications for activity. Like the activated holophos-
phorylase kinase, Phkytrnc appears to exhibit significant
ATPase activity. This is consistent with the active confor-
mations of the binary complexes of the enzyme and the
accessibility of the nucleotide's phosphate groups to
water molecules, as discussed in this work. Therefore it
appears that this protein kinase does not rely on an
induced-fit mechanism to prevent wasteful uncontrolled
hydrolysis of ATP. Instead, the holoenzyme utilizes the
controls conferred by the C-terminal, regulatory domain
through its interactions with Ca2 +/calmodulin and its
association with the oa- and 1-subunits to ensure that the
kinase is inactive until required and that the ATPase
activity is kept to a minimum.
It is interesting to note that four of the five positions at
which there are additional residues in Phkytrnc as com-
pared with cAPK (see Fig. 3) fall on one surface of the
protein, which includes the activation loop and the loop
between the 3 strand and helix C, as can be seen in
Figure 4. This surface of the protein contains some sec-
tions of peptide chain with poorly defined electron den-
sity or high temperature factors, including helix G,
which despite its hydrophobicity is exposed to solvent.
These factors, in combination with biochemical studies
carried out on cAPK and p34cdc2 , suggest that this pro-
tein surface could provide the location for binding of the
or- and 1-regulatory subunits and the y-subunit's own
regulatory domain.
Biological implications
As the major effectors of cellular control mecha-
nisms, protein kinases are tightly and accurately
regulated. The consequences of an inappropriately
active kinase in a cell are potentially catastrophic,
as demonstrated by the many oncogenic kinases.
Protein kinases are maintained in an 'off' state, and
are only activated in response to a specific signal,
after which they revert to the off state once more.
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Many protein kinases use phosphorylation as the
activating signal. Phosphorylation usually occurs
on a particular segment of peptide chain, termed
the activation loop, that is located at the mouth of
the cleft between the N- and C-terminal domains
of the kinase. The covalently bound phosphate
group forms a network of interactions which
serve to stabilize the catalytically competent con-
formation of the kinase by correctly orienting the
components of the phosphate transfer machinery.
A feature common to all kinases that are activated
by phosphorylation is an arginine residue adjacent
to the catalytic base. This arginine can interact
with the phosphorylated residue, and may serve to
transmit information directly from the activation
loop to the catalytic machinery. The activation
loop, including the phosphorylated residue, may
also play a role in the binding of the regulatory
subunit, as indicated by biochemical studies on
cAPK and p34 cdc2. The conformation of the acti-
vation loop plays a major role, therefore, in defin-
ing the activation state of the kinase.
Instead of being regulated by phosphorylation of
their activation loop, kinases can be regulated
through intrasteric inhibition by a pseudosub-
strate, as seen in twitchin kinase [23]. In these
kinases there is no residue that can be phosphoryl-
ized in the activation loop and the arginine
residue adjacent to the catalytic residue is not
conserved, indicating that the information trans-
mission system proposed in phosphorylation-reg-
ulated kinases is not in use.
The y-subunit of Phk is thought to be regulated
both by a peptide pseudosubstrate mechanism
involving its C-terminal domain and allosterically
by its two large, regulatory subunits (o- and
0-subunits) depending on their state of phospho-
rylation. Examination of the structure of the cat-
alytic kinase core of the Phk y-subunit provides an
explanation for how this is achieved. In place
of a residue in the activation loop that could
be phosphorylated, there is a glutamate, which,
functionally mimics the presence of a constitu-
tively present phosphorylated group, thus trapping
the activation loop in an active conformation. Phk
also possesses the conserved arginine seen in all
kinases that transmit information by phosphoryla-
tion from the activation loop. The interaction of
this glutamate residue with the conserved arginine
may provide a method of communication
between the catalytic machinery and the activa-
tion loop, enabling information to be transduced
from bound regulatory subunits while still allow-
ing regulation by Ca2+/calmodulin via an intra-
steric pseudosubstrate mechanism.
The increased number of residues that are found
in surface structures of the Phk y-subunit adjacent
to the activation loop and their unusually
hydrophobic nature, given their solvent accessible
environment, support the hypothesis that the large
regulatory subunits may bind in this region. We
propose that the effect of this binding may be
communicated to the active site by interaction of
the glutamate in the activation loop with the argi-
nine residue adjacent to the catalytic base.
Materials and methods
Protein production
As previously described [16], Phkytrnc comprises residues
1-298 of the rabbit muscle Phk y-subunit. The complemen-
tary DNA (cDNA) encoding Phk'ytrnc was constructed by
introducing translational stop codons at positions 299 and 300
in the Phk y-subunit cDNA by site directed mutagenesis using
oligonucleotide. The Phk-ytrnc cDNA was subcloned into the
T7 polymerase driven bacterial overexpression vector,
pMW172 [57]. When overexpressed in Escherichia coli the pro-
tein was produced in an insoluble form. This insoluble protein
was solubilized in 8 M urea and renatured by chaotrope dilu-
tion. Phkytmrnc was purified by ion exchange and Cibacron
blue affinity chromatography. Crystallizations were carried out
within three days of the final purification step.
Mg2+/ADP complex
Crystallization: The protein was crystallized by the method of
vapour diffusion (hanging drop) from drops containing 3 1 of
protein solution (10-12 mg ml-1 Phkytrnc, 3 mM ATP,
10 mM Mg(OAc)2, 10 mM HEPES/NaOH, 2% v/v glycerol,
10 mM DTT, 0.02% w/v NaN 3, 0.1 mM EDTA, pH 8.2) and
3 pI1 of reservoir solution (5% w/v PEG 8000, 50 mM
HEPES/NaOH, 10% v/v glycerol, 10 mM DTT, 0.02% w/v
NaN 3, pH 6.9) at a temperature of 160C. Crystals were first
observed about 18 h after setting up the drops and continued
to grow for 3-4 days. For crystal mounting, crystals were trans-
ferred to a solution of 8% w/v PEG 8000, 3 mM ATP, 10 mM
Mg(OAc)2 , 50 mM HEPES/NaOH, 10% v/v glycerol,
10 mM DTT, 0.02% w/v NaN3, pH 6.9.
X-ray data collection: X-ray diffraction data to 3.0 A resolution
were collected from two crystals with dimensions of approxi-
mately 50 Rpm x 50 m x 250 Rpm on Station 9.5 at the Syn-
chrotron radiation source, Daresbury, Warrington, UK,
equipped with an 18 cm diameter Mar Research image plate.
The synchrotron was operated at 2 GeV, the current was
150 mA and the wavelength was 0.92 A. The crystal to detec-
tor distance was 283 mm to give a resolution of 3.0 A at the
edge of the plate. Exposures were 300 s per 1.50 oscillations
and data were collected over a total of 90° rotation. The crys-
tals were orthorhombic space group P212121 with unit cell
dimensions a=47.9 A, b=69.1 A and c=112.9 A and had one
molecule of Phkytrnc (Mr 32000) per asymmetric unit. Data
were processed using DENZO and its companion program
SCALEPACK [58]. Partially recorded reflections were not
included in this data set. The oscillation angle used (1.5°)
allowed most of the reflections to be fully recorded, as the
spots possessed a mosaic spread of 0.3 °, as deduced from post-
processing of the data with SCALEPACK. There was a sharp
decrease in intensities for reflections between 3.1 A and 3.0 A
and in this resolution range the data were 81.7% complete with
an Rter of 0.486. Data between 3.1 A and 3.0 A were, how-
ever, included in the refinement, as refinements that used these
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data produced lower free R-values than equivalent refine-
ments. Statistics for the data set are given in Table 1.
Mn2+ /AMPPNP complex
Crystallization: The protein was crystallized by the method of
vapour diffusion (hanging drop) from drops containing 3 tl of
protein solution (10-12 mg ml- ' Phkytrnc, 3 mM AMPPNP,
10 mM HEPES/NaOH, 2% v/v glycerol, 10 mM DTT, 0.02%
w/v NaN 3, 0.1 mM EDTA, pH 8.2) and 3 1 of reservoir
solution (5% w/v PEG 8000, 50 mM HEPES/NaOH, 10mM
MnCl, 10% v/v glycerol, 10 mM DTT, 0.02% w/v NaN 3,
pH 6.9) at a temperature of 14°C. Crystals were first observed
about 72 h after setting up the drops and continued to grow for
5-6 days. Crystals were harvested into a solution of 12.5% w/v
PEG 8000, 3 mM AMPPNP, 3 mM MnCI2, 50 mM
HEPES/NaOH, 10% v/v glycerol, 10 mM DTT, pH 6.9.
X-ray data collection: Data were collected using the technique of
cryocrystallography at a temperature of 100 K [59]. The crys-
tals were transferred to a solution of 12.5% w/v PEG 8000,
3 mM AMPPNP, 3 mM MnCl, 50 mM HEPES/NaOH,
50% v/v glycerol, 4 mM DTT, pH 6.9 for 4 min. The crystals
were then taken up in a 0.75 mm angora wool fibre loop and
mounted on a modified goniometer head in a gaseous nitrogen
stream at 100 K generated by an Oxford Cryostream (STOR
Diffraction Systems, Maidenhead, Berkshire, UK).
X-ray diffraction data to 2.55 A resolution were collected
from one crystal with dimensions of approximately
100 p.mX 100 .mx300 J.um on station BW7B at DESY,
Hamburg, equipped with a 30 cm diameter Mar Research
image plate detector used in 18 cm mode. The synchrotron was
operated at 4.45 GeV and the wavelength was 0.87 A. The
crystal to detector distance was 250 mm to give a resolution of
2.55 A at the reading edge of the plate. Data were collected on
dose mode using 1.3° oscillations over a total of 90 ° rotation.
The crystals were orthorhombic space group P212121 with unit
cell dimensions a=48.5 A, b=68.1 A, c=113.3 A and one mol-
ecule of Phkytrnc (Mr 32000) per asymmetric unit. Data were
processed using DENZO and its companion program
SCALEPACK [58]. Partially recorded reflections were included
in this data set. Statistics of this dataset are given in Table 1.
Although radiation damage effects are lower for a frozen
crystal, a significant increase in the mosaic spread of the data
was observed after 6 h, indicating radiation damage due to the
intensity of the incident beam.
Structure solution
The structure was solved by molecular replacement using a
truncated copy (residues 43-280) of the ternary complex of the
cAMP-dependent protein kinase (Protein Data Bank code
4CPK) as a search model. Additional truncations of the search
model were made in regions where cAPK and Phkytrnc differ
by insertions or deletions. Molecular replacement was per-
formed using the lower resolution Mg2+/ATP dataset, as the
higher resolution dataset was not yet available. Either of the
two programs X-PLOR [60] or AMoRe [61] was able to
determine unambiguously the rotational and translational com-
ponents of the molecular replacement search. In AMoRe the
highest peak for the rotation function search in the resolution
range 10-4 A was 6 and the next highest peak was 4. The
translation function gave a correct solution with a correlation
coefficient of 31.5% and a crystallographic R-value of 49.6%,
compared to the next highest solution, which had a correlation
coefficient of only 14.1%. An electron-density map, based on
phases obtained from the molecular replacement solution,
proved easy to interpret over the entire length of the polypep-
tide chain, with side-chain positions apparent for most
Phk-ytrnc residues. Model building and refinement were pur-
sued with alternate cycles of manual refitting using O [25], and
simulated annealing using X-PLOR, until an R-value of
23.6% with a free R-value of 35.4% were obtained. At this
point, the higher resolution dataset was obtained from crystals
grown in the presence of Mn2 +/AMPPNP, and further refine-
ment, beginning with rigid-body refinement, was continued
against these data. Strong electron density at the kinase
nucleotide binding site indicated the presence of
Mn 2+/AMPPNP, which was modelled and refined accord-
ingly. When the conventional R-value reached 25%, water
molecules were added to the atomic model at the positions of
large positive peaks (>3r) in F-F c electron density, only
where the resultant water molecule fell in an appropriate
hydrogen bonding environment. Temperature factors were
refined initially on the basis of two groups per residue, and
then with an isotropic temperature-factor for each atom. Intro-
duction of each of these refinement steps gave rise to a decrease
in both the conventional and free R-values. Statistics of the
final Mn 2+/AMPPNP complex model are shown in Table 1.
The protein part of the Mn2+/AMPPNP complex structure
was refined in rigid body groups against the Mg 2+/ADP data.
SIGMAA [62] weighted 2mFo-DF c and Fo-Fc electron-density
maps were calculated using the resulting model, against which
the fit to density was evaluated. The F-F c map revealed elec-
tron-density only for an ADP moiety and two Mg 2+ ions at
the nucleotide-binding site. These were included in the atomic
model for subsequent refinement by energy minimization. An
additional manual intervention was necessary in the region of
the nucleotide phosphate binding loop, which appeared to
have adopted a slightly more closed conformation in the
Mg 2+/ADP complex. Grouped temperature factors and then
individual atomic temperature factors were refined. Despite the
low resolution of the available data (3.0 A), both of these
refinement steps gave rise to decreases in R-value and free
R-value. Statistics of the refined Mg 2+/ADP complex are
given in Table 1.
Coordinates have been submitted to the Brookhaven Protein
Data Bank.
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